FATROXIMIN DRY COW, intramaminė suspensija
FATROXIMIN DRY COW, intramaminė suspensija
Authorised
- Rifaximin
Product identification
Medicine name:
FATROXIMIN DRY COW, intramaminė suspensija
Active substance:
- Rifaximin
Target species:
-
Cattle (cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Rifaximin100.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
- Cattle (cow)
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51XX01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Available in:
-
Lithuania
Package description:
- Available only in Lithuanian
- Available only in Lithuanian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- LT/2/01/1284/001-002
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
RV1284.pdf
Lithuanian (PDF)
Download Published on: 8/06/2022
How useful was this page?:
